Article ID Journal Published Year Pages File Type
5695282 Gynecologic Oncology 2017 5 Pages PDF
Abstract

- Consider exemestane plus ovarian function suppression for premenopausal HR + women
- Premenopausal HR + breast cancer patients should be treated with tamoxifen (10 yrs).
- Premenopausal HR + breast cancer pts may benefit from endocrine therapy and ovarian function suppression.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer
Authors
, ,